Pharma Reviews: GlaxoSmithKline Pharma net dips by over 63% in Q1
The pharmaceutical trade channels de-stocked impacting the overall ... pipeline and reviewing these for a possible launch for its Indian patients.
Read more: GlaxoSmithKline Pharma net dips by over 63% in Q1